Civica announces a partnership with Avera to help protect patients from the impact of shortages of generic sterile injectable medicines. Under the Civica model, hospitals enter market-stabilizing contracts directly; all members are offered the same cost-plus price for these products, regardless of hospital size. The company strives to provide 6 months of buffer inventory and prioritizes US-based suppliers, helping to ensure quality products.